TransMedics Group, Inc.
TMDX
$87.72
-$0.52-0.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.86M | 4.22M | 12.19M | 12.20M | 4.03M |
| Total Depreciation and Amortization | 5.68M | 5.18M | 4.60M | 4.30M | 3.61M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.96M | 8.71M | 8.75M | 8.16M | 6.23M |
| Change in Net Operating Assets | -5.83M | -11.25M | 177.00K | -28.10M | -5.56M |
| Cash from Operations | 19.66M | 6.86M | 25.72M | -3.44M | 8.30M |
| Capital Expenditure | -13.61M | -48.20M | -23.76M | -44.17M | -41.82M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 441.00K | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -13.61M | -47.76M | -23.76M | -44.17M | -41.82M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 1.19M | 7.86M | 10.64M | 3.19M | 924.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 1.19M | 7.86M | 10.64M | 3.19M | 924.00K |
| Foreign Exchange rate Adjustments | -687.00K | 386.00K | -62.00K | -173.00K | 292.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.56M | -32.66M | 12.53M | -44.60M | -32.30M |